Pharmaceutical distribution: Difference between revisions
CSV import |
CSV import |
||
| Line 39: | Line 39: | ||
{{stub}} | {{stub}} | ||
<gallery> | |||
File:Examining_Bulk_Drug_Containers_(FDA_100)_(8250838700).jpg|Examining bulk drug containers | |||
File:Laboratoires_Arkopharma_-_Chaine_de_conditionnement_remplissage_piluliers.JPG|Laboratoires Arkopharma - Packaging line | |||
File:Cold_control_packaging.jpg|Cold control packaging | |||
</gallery> | |||
Latest revision as of 04:20, 18 February 2025
Pharmaceutical distribution refers to the process of delivering medications and other healthcare products from the point of manufacture to the point of use. This involves a complex network of various entities, including manufacturers, wholesalers, pharmacies, hospitals, and patients.
Etymology[edit]
The term "pharmaceutical" is derived from the Greek word "pharmakeia," which means "use of drugs, medicines, potions, or spells; poisoning, witchcraft." The term "distribution" comes from the Latin word "distributio," which means "a division or distribution."
Process[edit]
The pharmaceutical industry produces drugs and other healthcare products. These products are then distributed to various entities in the healthcare system. The distribution process typically involves the following steps:
- Manufacturing: The pharmaceutical company manufactures the drugs and other healthcare products.
- Wholesale: The products are sold to wholesalers, who buy in bulk and store the products in their warehouses.
- Retail: The wholesalers sell the products to pharmacies and hospitals.
- Patient: The pharmacies and hospitals provide the products to patients.
Entities involved[edit]
The pharmaceutical distribution process involves various entities, including:
- Pharmaceutical companies: These are the manufacturers of drugs and other healthcare products.
- Wholesalers: These entities buy products in bulk from manufacturers and sell them to pharmacies and hospitals.
- Pharmacies: These are retail outlets where patients can buy drugs and other healthcare products.
- Hospitals: These are healthcare institutions that provide treatment and care to patients. They also buy drugs and other healthcare products from wholesalers.
- Patients: These are the end-users of the drugs and other healthcare products.
Challenges[edit]
The pharmaceutical distribution process faces several challenges, including:
- Counterfeit drugs: The World Health Organization estimates that 10% of drugs worldwide are counterfeit. This poses a significant risk to patient safety.
- Supply chain inefficiencies: The complex nature of the pharmaceutical supply chain can lead to inefficiencies, such as stockouts and wastage.
- Regulatory compliance: Pharmaceutical companies, wholesalers, and pharmacies must comply with various regulations to ensure the safety and efficacy of their products.


